Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026)
Fate Therapeutics (FATE) posted Prepaid Assets of $4.0 million for Q1 2026, down 3.17% on a QoQ basis from $4.1 million in Q4 2025, and down 25.73% year-over-year from $5.4 million in Q1 2025.
Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026) Analysis & Trends
Fate Therapeutics' Prepaid Assets history runs 15 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- Quarterly Prepaid Assets fell 25.73% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 25.73% YoY) and the FY2025 annual result came in at $4.1 million, down 55.59% from the prior year.
- Prepaid Assets was $4.0 million for Q1 2026 at Fate Therapeutics, down from $4.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $27.4 million in Q4 2022 and bottomed at $4.0 million in Q1 2026.
- A 5-year average of $11.6 million and a median of $11.4 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 210.07% — and 2025, when it slumped 55.59%.
- Fate Therapeutics' Prepaid Assets stood at $27.4 million in 2022, then plunged by 46.87% to $14.5 million in 2023, then tumbled by 36.02% to $9.3 million in 2024, then slumped by 55.59% to $4.1 million in 2025, then slipped by 3.17% to $4.0 million in 2026.
- Business Quant data shows FATE's Prepaid Assets at $4.0 million in Q1 2026, $4.1 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.13 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 9.24 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | 12.90 Mn |
| Jun 30, 2023 | 11.41 Mn |
| Mar 31, 2023 | 15.49 Mn |
| Dec 31, 2022 | 27.37 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 17.18 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 8.83 Mn |
| Sep 30, 2021 | 7.70 Mn |
| Jun 30, 2021 | 7.37 Mn |